This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
C.O. Adewunmi , B. Oguntimein & P. Furu (1990) Molluscicidal and antischistosomal activity of Zingiber officinale. Planta Medica 39, 57–65.
Anon, (1994) Pharmaceuticals from plants: great potential, few funds. Editorial, The Lancet 343, 1513–1515.
M.L. Barreto , D.H. Smith & A.D. Sleigh (1990) Implications of faecal egg count variation when using the Kato-Katz method to assess Schistosoma mansoni infections. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 554–555.
N.R. Bergquist (1995) Controlling schistosomiasis by vaccination: a realistic option? Parasitology Today 11, 191–194.
P.J. Brindley (1994) Drug resistance to schistosomicides and other anthelmintics of medical significance. Acta Tropica 56, 213–231.
A.E. Butterworth (1994) Human immunity to schistosomes: some questions. Parasitology Today 10, 378–380.
J.B. Calixto (2000) Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Brazilian Journal of Medical and Biological Research 33, 179–189.
D. Cioli , L. Pica-Mattoccia & S. Archer (1993) Drug resistance in schistosomes. Parasitology Today 9, 162–166.
G.M. Cragg , D.J. Newman & K.M. Snader (1997) Natural products in drug discovery and development. Journal of Natural Products 60, 52–60.
R. El-ridi , T. Ozaki , T. Inaba , M. Ito & H. Kamiya (1997) Schistosoma mansoni oviposition in vitro reflects worm fecundity in vivo: individual, parasite age and host-dependent variations. International Journal for Parasitology 27, 381–387.
P.G. Fallon (1998) Schistosome resistance to praziquantel. Drug Resistance Updates 1, 236–241.
P.G. Fallon , P. Smith , T. Nicholls , J. Modha & M.J. Doenhoff (1994) Praziquantel-induced exposure of Schistosoma mansoni alkaline phosphatase: drug-antibody synergy which acts preferentially against female worms. Parasite Immunology 16, 529–535.
B. Gryseels (2000) Schistosomiasis vaccines: a devils advocate view. Parasitology Today 16, 46–48.
J.T. Jones , P. Breeze & J.R. Kusel (1989) Schistosome fecundity: influence of host genotype and intensity of infection. International Journal for Parasitology 19, 769–777.
C. Pereira , P.G. Fallon , J. Cornette , A. Capron , M.J. Doenhoff & R.J. Pierce (1998) Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni. Parasitology 117, 63–73.
A.A. Sabah , C. Fletcher , G. Webbe & M.J. Doenhoff (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology 61, 294–303.
L. Salvioli , E. Renganathan , A. Montresor , A. Davis & K. Behbehani (1997) Control of schistosomiasis–a global picture. Parasitology Today 13, 444–448.
D. Schirazian & E.L. Schiller (1983) A technique for selecting uniform samples of Schistosoma mansoni based on egg production. Journal of Parasitology 69, 989–990.
A.C. Sleigh , K.E. Mott , J.T. Franca Silva , T.M. Muniz , E.A. Mota , M.L. Barreto , R. Hoff , J.H. Maguire , J.S. Lehman & I. Sherlock (1981) A three year follow up of chemotherapy with oxamniquine in a Brazilian community with endemic schistosomiasis mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene 75, 234–238.
O.D. Standen (1949) Experimental schistosomiasis II: maintenance of Schistosoma mansoni in the laboratory, with some notes on experimental infection with S. haematobium. Annals of Tropical Medicine and Parasitology 43, 268–283.